Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | COVID-19 and cancer outcomes in the UK

David Pinato • 16 Apr 2021
General

David Pinato, MD, MRes, PhD, Imperial College London, London, UK, discusses his presentation on the OnCovid study which is investigating the outcomes of patients with cancer during the COVID-19 pandemic. Data from over 3,000 patients has been analyzed in the study. The study has reported an increased mortality rate in cancer patients in the UK, associated with age and fraility. Dr Pinato recommends that cancer patients receive the COVID-19 vaccine, commenting on the potential impacts of certain hematological malignancies on vaccine efficiency. This interview took place during the 19th British Thoracic Oncology Group (BTOG) Annual Conference 2021.

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals